Skip to main content
. 2023 Apr 24;6(4):e239196. doi: 10.1001/jamanetworkopen.2023.9196

Table 3. Associations of Regional ePVS Volumes With Vascular Risk Factorsa.

Vascular risk factor Anatomic location
Basal ganglia, −1 × x−0.125 Thalamus, x0.325 Insular region, x0.35 Brainstem, x0.45 Frontoparietal region, x0.05 Temporal region, ln(x)
β (95% CI) P value β (95% CI) P value β (95% CI) P value β (95% CI) P value β (95% CI) P value β (95% CI) P value
SBP, per mm Hg 8.35 × 10−4 (5.19 × 10−4 to 1.15 × 10−3) <.001b 1.60 × 10−4 (2.54 × 10−5 to 2.95 × 10−4) .02 1.28 × 10−5 (−1.37 × 10−4 to 1.63 × 10−4) .87 7.84 × 10−6 (−4.51 × 10−5 to 6.08 × 10−5) .77 1.14 × 10−4 (3.38 × 10−5 to 1.95 × 10−4) .005b 2.69 × 10−3 (5.85 × 10−4 to 4.79 × 10−3) .01
Use of antihypertensives 3.29 × 10-2 (1.92 × 10−2 to 4.67 × 10−2) <.001 1.19 × 10−2 (6.02 × 10−3 to 1.77 × 10−2) <.001b 2.77 × 10−5 (−6.51 × 10−3 to 6.57 × 10−3) .99 1.96 × 10−3 (−3.43 × 10−4 to 4.27 × 10−3) .10 9.96 × 10−4 (−2.51 × 10−3 to 4.50 × 10−3) .58 5.01 × 10−2 (−4.14 × 10−2 to 1.42 × 10−1) .28
Diabetes −1.52 × 10−3 (−1.72 × 10−2 to 1.41 × 10−2) .85 −4.65 × 10−3 (−1.13 × 10−2 to 2.02 × 10−3) .17 7.93 × 10−3 (4.91 × 10−4 to 1.54 × 10−2) .04 −3.21 × 10−4 (−2.94 × 10−3 to 2.30 × 10−3) .81 4.90 × 10−3 (9.20 × 10−4 to 8.89 × 10−3) .02 1.25 × 10−1 (2.13 × 10−2 to 2.30 × 10−1) .02
Hyperlipidemia 6.62 × 10−3 (−6.59 × 10−3 to 1.98 × 10−2) .33 1.22 × 10−3 (−4.41 × 10−3 to 6.84 × 10−3) .67 −6.52 × 10−3 (−1.28 × 10−2 to −2.42 × 10−4) .04 −7.36 × 10−4 (−2.95 × 10−3 to 1.48 × 10−3) .52 −2.75 × 10−3 (−6.11 × 10−3 to 6.16 × 10−4) .11 −4.42 × 10−2 (−1.32 × 10−1 to 4.37 × 10−2) .33
Smoking −3.69 × 10−3 (−1.63 × 10−2 to 8.89 × 10−3) .57 −5.06 × 10−4 (−5.87 × 10−3 to 4.86 × 10−3) .85 4.79 × 10−5 (−5.93 × 10−3 to 6.03 × 10−3) .99 1.62 × 10−4 (−1.95 × 10−3 to 2.27 × 10−3) .88 −2.17 × 10−3 (−5.37 × 10−3 to 1.04 × 10−3) .19 −8.04 × 10−2 (−1.64 × 10−1 to 3.24 × 10−3) .06
Alcohol −7.01 × 10−3 (−2.03 × 10−2 to 6.27 × 10−3) .30 1.18 × 10−3 (−4.48 × 10−3 to 6.84 × 10−3) .68 −2.12 × 10−3 (−8.43 × 10−3 to 4.19 × 10−3) .51 1.41 × 10−3 (−8.11 × 10−4 to 3.64 × 10−3) .21 3.20 × 10−4 (−3.06 × 10−3 to 3.70 × 10−3) .85 −2.12 × 10−2 (−1.10 × 10−1 to 6.71 × 10−2) .64
WHR 7.90 × 10−2 (−1.23 × 10−2 to 1.70 × 10−1) .09 −2.40 × 10−2 (−6.29 × 10−2 to 1.49 × 10−2) .23 −1.20 × 10−2 (−5.54 × 10−2 to 3.14 × 10−2) .59 −2.00 × 10−2 (−3.53 × 10−2 to −4.74 × 10−3) .01 −2.42 × 10−2 (−4.75 × 10−2 to −9.79 × 10−4) .04 −7.08 × 10−1 (−1.32 to −1.01 × 10 ) .02
Physical activity, x0.375 −3.79 × 10−5 (−7.53 × 10−4 to 6.78 × 10−4) .92 −4.19 × 10−6 (−3.09 × 10−4 to 3.01 × 10−4) .98 3.28 × 10−5 (−3.07 × 10−4 to 3.73 × 10−4) .85 −5.05 × 10−5 (−1.70 × 10−4 to 6.94 × 10−5) .41 −8.22 × 10−5 (−2.64 × 10−4 to 9.99 × 10−5) .38 6.03 × 10−4 (−4.15 × 10−3 to 5.36 × 10−3) .8

Abbreviations: ePVS, enlarged perivascular space; MET, metabolic equivalent of task; SBP, systolic blood pressure; WHR, waist-to-hip ratio.

a

Results from generalized linear models with regional ePVS volumes as the outcomes, and vascular risk factors as variables; models were adjusted for age, sex, race and ethnicity, field center, and total intracranial volume. Regional ePVS volumes and intentional physical activity (in MET/min/week) have undergone the Tukey ladder of powers transformation. Values represent β coefficients, reflecting the change in the transformed response variable for 1-increment increase in the variable and their 95% CIs and raw P values.

b

Significant after false-discovery rate control at 5% using the Benjamini-Hochberg procedure.